A dedicated session of the second PRESTIGIO Ring will discuss complicated cases of ARV therapeutic management of HTE-PLWH enrolled in the Registry.

To have the opportunity to contribute to the discussion during this congress session, please write to [email protected].

The three most relevant cases will be selected by the Steering Committee. If you would like to participate, please write a one-page abstract detailing the treatment history, resistance profile, and the clinical problem you would like to address.